Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9367201rdf:typepubmed:Citationlld:pubmed
pubmed-article:9367201lifeskim:mentionsumls-concept:C0302908lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C0006462lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C1442989lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C0442711lld:lifeskim
pubmed-article:9367201lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:9367201pubmed:issue1-2lld:pubmed
pubmed-article:9367201pubmed:dateCreated1997-12-19lld:pubmed
pubmed-article:9367201pubmed:abstractTextA rapid and systematic LC-MS protocol is utilized to profile buspirone metabolites. Analysis of rat bile, urine and liver S9 samples using a standard LC-MS method provides structural information for 25 metabolites. The resulting buspirone metabolite structure database contains characteristic retention time, molecular mass and MS-MS product ion information for each compound. Metabolites are categorized according to profile groups, which illustrate that substitution reactions are primarily associated with the azaspirone decane dione and pyrimidine substructures. Structures of new buspirone metabolites are reported and include the despyrimidinyl, despyrimidinylpiperazine, glucuronide, hydroxyglucuronide (four isomers), methoxyglucuronide and hydroxymethoxyglucuronide (two isomers) buspirone metabolites.lld:pubmed
pubmed-article:9367201pubmed:languageenglld:pubmed
pubmed-article:9367201pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9367201pubmed:citationSubsetIMlld:pubmed
pubmed-article:9367201pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9367201pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9367201pubmed:statusMEDLINElld:pubmed
pubmed-article:9367201pubmed:monthSeplld:pubmed
pubmed-article:9367201pubmed:issn1387-2273lld:pubmed
pubmed-article:9367201pubmed:authorpubmed-author:LeeM SMSlld:pubmed
pubmed-article:9367201pubmed:authorpubmed-author:VolkK JKJlld:pubmed
pubmed-article:9367201pubmed:authorpubmed-author:KernsE HEHlld:pubmed
pubmed-article:9367201pubmed:authorpubmed-author:RourickR ARAlld:pubmed
pubmed-article:9367201pubmed:issnTypePrintlld:pubmed
pubmed-article:9367201pubmed:day26lld:pubmed
pubmed-article:9367201pubmed:volume698lld:pubmed
pubmed-article:9367201pubmed:ownerNLMlld:pubmed
pubmed-article:9367201pubmed:authorsCompleteYlld:pubmed
pubmed-article:9367201pubmed:pagination133-45lld:pubmed
pubmed-article:9367201pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:meshHeadingpubmed-meshheading:9367201-...lld:pubmed
pubmed-article:9367201pubmed:year1997lld:pubmed
pubmed-article:9367201pubmed:articleTitleBuspirone metabolite structure profile using a standard liquid chromatographic-mass spectrometric protocol.lld:pubmed
pubmed-article:9367201pubmed:affiliationBristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903-0191, USA.lld:pubmed
pubmed-article:9367201pubmed:publicationTypeJournal Articlelld:pubmed